Blood polyphenol concentrations and differentiated thyroid carcinoma in women from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

EPIC biomarkers nested case–control study polyphenol thyroid cancer

Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
04 Jan 2021
Historique:
received: 26 03 2020
accepted: 07 09 2020
pubmed: 7 10 2020
medline: 7 10 2020
entrez: 6 10 2020
Statut: ppublish

Résumé

Polyphenols are natural compounds with anticarcinogenic properties in cellular and animal models, but epidemiological evidence determining the associations of these compounds with thyroid cancer (TC) is lacking. The aim of this study was to evaluate the relations between blood concentrations of 36 polyphenols and TC risk in EPIC (the European Prospective Investigation into Cancer and Nutrition). A nested case-control study was conducted on 273 female cases (210 papillary, 45 follicular, and 18 not otherwise specified TC tumors) and 512 strictly matched controls. Blood polyphenol concentrations were analyzed by HPLC coupled to tandem MS after enzymatic hydrolysis. Using multivariable-adjusted conditional logistic regression models, caffeic acid (ORlog2: 0.55; 95% CI: 0.33, 0.93) and its dehydrogenated metabolite, 3,4-dihydroxyphenylpropionic acid (ORlog2: 0.84; 95% CI: 0.71, 0.99), were inversely associated with differentiated TC risk. Similar results were observed for papillary TC, but not for follicular TC. Ferulic acid was also inversely associated only with papillary TC (ORlog2: 0.68; 95% CI: 0.51, 0.91). However, none of these relations was significant after Bonferroni correction for multiple testing. No association was observed for any of the remaining polyphenols with total differentiated, papillary, or follicular TC. Blood polyphenol concentrations were mostly not associated with differentiated TC risk in women, although our study raises the possibility that high blood concentrations of caffeic, 3,4-dihydroxyphenylpropionic, and ferulic acids may be related to a lower papillary TC risk.

Sections du résumé

BACKGROUND BACKGROUND
Polyphenols are natural compounds with anticarcinogenic properties in cellular and animal models, but epidemiological evidence determining the associations of these compounds with thyroid cancer (TC) is lacking.
OBJECTIVES OBJECTIVE
The aim of this study was to evaluate the relations between blood concentrations of 36 polyphenols and TC risk in EPIC (the European Prospective Investigation into Cancer and Nutrition).
METHODS METHODS
A nested case-control study was conducted on 273 female cases (210 papillary, 45 follicular, and 18 not otherwise specified TC tumors) and 512 strictly matched controls. Blood polyphenol concentrations were analyzed by HPLC coupled to tandem MS after enzymatic hydrolysis.
RESULTS RESULTS
Using multivariable-adjusted conditional logistic regression models, caffeic acid (ORlog2: 0.55; 95% CI: 0.33, 0.93) and its dehydrogenated metabolite, 3,4-dihydroxyphenylpropionic acid (ORlog2: 0.84; 95% CI: 0.71, 0.99), were inversely associated with differentiated TC risk. Similar results were observed for papillary TC, but not for follicular TC. Ferulic acid was also inversely associated only with papillary TC (ORlog2: 0.68; 95% CI: 0.51, 0.91). However, none of these relations was significant after Bonferroni correction for multiple testing. No association was observed for any of the remaining polyphenols with total differentiated, papillary, or follicular TC.
CONCLUSIONS CONCLUSIONS
Blood polyphenol concentrations were mostly not associated with differentiated TC risk in women, although our study raises the possibility that high blood concentrations of caffeic, 3,4-dihydroxyphenylpropionic, and ferulic acids may be related to a lower papillary TC risk.

Identifiants

pubmed: 33021645
pii: S0002-9165(22)00569-X
doi: 10.1093/ajcn/nqaa277
pmc: PMC7779226
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-171

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Regional Governments of Andalucía
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Dutch Prevention Funds
Organisme : Netherlands National Institute for Public Health and the Environment
Organisme : European Regional Development Fund
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : German Cancer Aid
Organisme : Swedish Research Council
Organisme : Hellenic Health Foundation
Organisme : Swedish Cancer Society
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Ligue Contre le Cancer
Organisme : International Agency for Research on Cancer
Organisme : Netherlands Cancer Registry
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Statistics Netherlands
Organisme : Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy
Organisme : Dutch Ministry of Health, Welfare and Sport
Organisme : Federal Ministry of Education and Research
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Institut National de la Santé et de la Recherche Médicale
Organisme : LK Research Funds
Organisme : Danish Cancer Society
Organisme : Instituto de Salud Carlos III
ID : CP15/00100
Organisme : European Commission (DG-SANCO)
Organisme : German Cancer Research Center
Organisme : World Cancer Research Fund
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : National Research Council
Organisme : Catalan Institute of Oncology-ICO
Organisme : Ministry of Education and Research
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : County Councils of Skåne and Västerbotten
Organisme : Health Research Fund
Organisme : Institut Gustave Roussy
Organisme : Mutuelle Générale de l'Education Nationale

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.

Auteurs

Raul Zamora-Ros (R)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.

Leila Lujan-Barroso (L)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.

David Achaintre (D)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Silvia Franceschi (S)

Oncology Referral Center (CRO), Aviano National Cancer Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.

Cecilie Kyrø (C)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Kim Overvad (K)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Therese Truong (T)

Versailles Saint-Quentin-en-Yvelines University (UVSQ), Université Paris-Saclay, Institut National de la Santé et de la Recherche Médicale, Centre for Research in Epidemiology and Population Health (CESP), Villejuif, France.
Gustave Roussy, Villejuif, France.

Lucie Lecuyer (L)

Versailles Saint-Quentin-en-Yvelines University (UVSQ), Université Paris-Saclay, Institut National de la Santé et de la Recherche Médicale, Centre for Research in Epidemiology and Population Health (CESP), Villejuif, France.
Gustave Roussy, Villejuif, France.

Marie-Christine Boutron-Ruault (MC)

Versailles Saint-Quentin-en-Yvelines University (UVSQ), Université Paris-Saclay, Institut National de la Santé et de la Recherche Médicale, Centre for Research in Epidemiology and Population Health (CESP), Villejuif, France.
Gustave Roussy, Villejuif, France.

Verena Katzke (V)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Theron S Johnson (TS)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Eleni Peppa (E)

Hellenic Health Foundation, Athens, Greece.

Carlo La Vechia (C)

Hellenic Health Foundation, Athens, Greece.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Giovanna Masala (G)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.

Valeria Pala (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Salvatore Panico (S)

Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, "Civic-MP Arezzo" Hospital, ASP Ragusa, Ragusa, Italy.

Fulvio Ricceri (F)

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Turin, Italy.

Guri Skeie (G)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

J Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Miguel Rodriguez-Barranco (M)

Andalusian School of Public Health, Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Pilar Amiano (P)

CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, BioDonostia Research Institute, Donostia-San Sebastian, Spain.

María-Dolores Chirlaque (MD)

CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, Murcia, Spain.

Eva Ardanaz (E)

CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.

Martin Almquist (M)

Department of Surgery, Endocrine-Sarcoma Unit, Skåne University Hospital, Lund, Sweden.

Joakim Hennings (J)

Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.

Roel Vermeulen (R)

Institute of Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands.
Department of Public Health, University Medical Center Utrecht, Utrecht, Netherlands.

Nicholas J Wareham (NJ)

Medical Research Council (MRC) Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Tammy Y N Tong (TYN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Dagfinn Aune (D)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Department of Nutrition, Bjørknes University College, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Graham Byrnes (G)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Elisabete Weiderpass (E)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Augustin Scalbert (A)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Sabina Rinaldi (S)

International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.

Classifications MeSH